Neupath Health ($NPTH.V) FINS Review

Q3 2024

Well what do we have here. A $70M TTM company trading at a miniscule $9M market cap.

The stock began trading back in 2020 and after some initial interest nose dived in mid 2022, and since then has been muddling between the 13 and 23 cent range primarily.

A few requests have come in recently. I’m guessing it is due to the only guy I can find who’s been talking about this lately - my buddy Cam over at Common Sense Investing. He intro’d the stock a couple of weeks ago on his YouTube channel, so that is a great place to start for a primer to get your feet wet.

So, what do the financials tell us? Is this a 2025 sleeper in the making?

---